← Back to screener

GENTEX CORP GNTX

Rank #73 · Nasdaq · $4.2B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
78.6
P/E
9.9
P/B
1.71
ROE
17.4%
Op. Margin
21.6%
Debt Ratio
12%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★☆
Excellent

P/E 9.9x, P/B 1.71x. Ranks in the top 19% of the universe.

Profitability ★★★★☆
Good

ROE 17.4%. Ranks in the top 22% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 12%. Ranks in the top 10% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Excellent

Revenue growth of 19.8% year over year. Ranks in the top 19% of the universe.

Valuation is the relative strength (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.1B$0.1B$0.7B–18
2012–$0.2B$0.1B$0.7B–36
2013–$0.2B$0.2B$0.9B–16
2014–$0.2B$0.2B$1.0B–42
2015–$0.3B$0.2B$1.1B–40
2016–$0.4B$0.3B$1.3B–32
2017–$0.5B$0.3B$1.6B–25
2018$1.7B$0.5B$0.3B$1.7B30.518
2019$1.8B$0.5B$0.4B$1.9B29.212
2020$1.8B$0.5B$0.4B$2.0B27.711
2021$1.9B$0.5B$0.4B$1.9B26.313
2022$1.7B$0.4B$0.3B$1.9B23.710
2023$1.7B$0.4B$0.4B$2.0B23.713
2024$1.9B$0.4B$0.3B$2.3B19.313
2025$2.3B$0.5B$0.4B$2.5B21.612

← See the full screener